Kyiv hit by massive missile strike as Zelenskyy calls for U.S. pressure on Russia
The Ukrainian capital came under a “massive” Russian missile attack early Thursday (12 February), with explosions heard across the capital accordi...
China has achieved a significant medical milestone, with its drug regulator announcing the approval of the country's first domestically developed 9-valent human papillomavirus (HPV) vaccine.
In a landmark development for public health, China's drug regulator has given the green light to the nation's first domestically developed 9-valent human papillomavirus (HPV) vaccine. The approval, announced Wednesday, marks a significant turning point, ending over a decade of foreign companies dominating the lucrative and critical HPV vaccine market within the country.
The newly approved vaccine is designed to target nine distinct strains of the human papillomavirus, making it only the second vaccine of its kind globally to offer such broad protection. HPV vaccines are widely recognised as crucial tools in preventing cervical cancer in women and genital cancers and warts in both men and women.
Human Papillomavirus (HPV) is a very common virus, primarily spread through close physical intimacy, with many types. While some types can cause warts, certain "high-risk" types are responsible for nearly all cases of cervical cancer, as well as other cancers in both men and women. Vaccination is a key method of prevention.
This approval represents a major stride in China's push for self-sufficiency in key pharmaceutical and healthcare sectors. It is expected to significantly bolster the country's vaccination efforts, potentially improving accessibility and affordability of this vital preventative measure for millions of Chinese citizens. The domestic production could also reduce reliance on international supply chains, ensuring more stable access to the vaccine.
Experts believe that the introduction of a homegrown 9-valent HPV vaccine will not only address a significant public health need but also stimulate further innovation within China's biopharmaceutical industry. This development is poised to have a profound impact on public health outcomes across China, offering robust protection against HPV-related diseases.
The United States and Azerbaijan signed a strategic partnership in Baku on Tuesday (10 February) encompassing economic and security cooperation as Washington seeks to expand its influence in a region where Russia was once the main power broker.
Greek Prime Minister Kyriakos Mitsotakis arrived in Ankara on Wednesday, where Turkish President Recep Tayyip Erdoğan held an official welcoming ceremony at the Presidential Palace, marking the start of high-level talks between the two NATO allies.
Europe heads into the Munich Security Conference, 13 February, amid deepening unease over U.S. policy, as President Donald Trump’s hard-line stance on defence, trade and territory fuels doubts about Washington’s long-term commitment to transatlantic security.
The European Union is preparing a further expansion of its sanctions against Russia, with Central Asia emerging for the first time as a distinct point of focus.
A senior adviser to Iran’s Supreme Leader said on Tuesday that negotiations with the United States must remain focused on the nuclear issue and be grounded in realism, as Washington and Tehran prepare to resume talks mediated by Oman.
Measles cases across Europe and Central Asia fell sharply in 2025 compared to the previous year but health officials have warned that the risk of fresh outbreaks remains unless vaccination gaps are urgently addressed.
A Florida university has become a new hotspot in a widening U.S. measles outbreak, with health officials confirming multiple infections and hospitalisations.
The World Health Organization has added the Nipah virus to its list of the world’s top 10 priority diseases, alongside COVID-19 and the Zika virus, warning that its epidemic potential highlights the global risk posed by fast-spreading outbreaks.
Belgian authorities are examining suspected cases of infants falling ill after consuming recalled Nestle baby formula, amid warnings that confirmed infections may be underestimated due to limited testing requirements.
Two Nipah infections involving health workers in India have triggered heightened screening across Southeast Asia as authorities move to prevent the high fatality virus from spreading beyond the country.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment